- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 16-12-2025: Press Release
16-12-2025 | 08:58 pm
16-12-2025 | 08:58 pm
Lupin's Nagpur injectable facility obtained a satisfactory US FDA Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) classification. This confirms strong operational compliance, a key positive for its manufacturing operations.
No comments yet. Be the first to comment!